Biodesix, Inc. (NASDAQ:BDSX) Q4 2023 Earnings Call Transcript
Operator: Good day and thank you for standing by. Welcome to the Biodesix's Fourth Quarter 2023 Earnings Conference Call. [Operator Instructions].
Biodesix Inc (BDSX)
Market is closed
Sector: Services-Medical Laboratories
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Birchview Capital Matthew Strobeck | 5,193,336 | $9,530,285 | 7.47% | |
| 2. | AIGH Investment Partners Orin Hirschman | 4,658,946 | $8,572,461 | -6% | 3.39% |
| 3. | Opaleye Management James A. Silverman | 496,500 | $3,610,660 | +9% | 0.96% |
| 4. | Millennium Management Israel Englander | 91,320 | $168,029 | +172% | 0% |
| 5. | Citadel Investment Group Ken Griffin | 26,177 | $48,166 | -42% | 0% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $1.71 | 87,500 | 30,707,722 | 2023-08-23 | Filing | ||
| $1.67 | 8,307 | 30,620,222 | 2023-08-22 | Filing | ||
| $1.64 | 32,556 | 30,611,915 | 2023-08-21 | Filing | ||
| $1.35 | 14,792 | 20,589,853 | 2023-05-31 | Filing | ||
| $1.36 | 11,849 | 20,575,061 | 2023-05-30 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $1.66 | 922 | 9,548 | 2024-02-12 | Filing | ||
| $1.92 | 1,077 | 10,470 | 2024-02-09 | Filing | ||
| $1.66 | 5,022 | 123,250 | 2024-02-12 | Filing | ||
| $1.92 | 5,862 | 128,272 | 2024-02-09 | Filing | ||
| $1.66 | 5,412 | 68,005 | 2024-02-12 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 1,141,794 | $2,100,901 | 1.13% | |
| 2. | 912,945 | $1,679,819 | 0.33% | |
| 3. | 883,653 | $1,625,921 | 0% | |
| 4. | 811,751 | $1,493,621 | 0% | |
| 5. | 404,461 | $744,208 | 0% |
News See All
Hedge Fund and Insider Trading News: Bill Ackman, Warren Buffett, Elliott Management, Odey Asset Management, BlueCrest Capital Management, Fortrea Holdings Inc (FTRE), Palo Alto Networks, Inc. (PANW), and More
In Bill Ackman’s view, Vivek Ramaswamy is simply misunderstood.
Biodesix, Inc. (NASDAQ:BDSX) Q2 2023 Earnings Call Transcript
Operator: Good day and thank you for standing by. Welcome to the Biodesix Second Quarter 2023 Earnings Conference Call. At this time, all participants are in a listen-only mode.
Biodesix, Inc. (NASDAQ:BDSX) Q1 2023 Earnings Call Transcript
Operator: Good day, and thank you for standing by and welcome to the Biodesix First Quarter 2023 Earnings Conference Call. At this time all participants are in a listen-only mode.
Biodesix, Inc. (NASDAQ:BDSX) Q4 2022 Earnings Call Transcript
Operator: Good day, and thank you for standing by. Welcome to the Biodesix Fourth Quarter and Year-End 2022 Earnings Conference Call. At this time all participants are in a listen-only mode.
Hedge Fund and Insider Trading News: Paul Tudor Jones, Ray Dalio, Michael Platt, Rokos Capital Management, Livermore Partners, Lynx Asset Management, B Riley Financial Inc (RILY), Biodesix, Inc. (BDSX), and More
Hedge fund billionaire Paul Tudor Jones likened Jerome Powell’s war against inflation to an attempt at a perfect moon landing, saying the Federal Reserve chair is facing the most challenging economic...
Hedge Fund and Insider Trading News: Marc Lasry, Michael Platt, Senvest Management, Maverick Capital, Muddy Waters Capital, Tramondo Investment Partners, Biodesix Inc (BDSX), and More
Marc Lasry, the co-founder, chairman and chief executive of private-equity firm and hedge-fund investor Avenue Capital, has seen plenty of success in the sports world, as the Milwaukee Bucks he co-owns...
5 Biotech Stocks to Buy According to Matthew Strobeck's Birchview Capital
In this article, we discuss 5 biotech stocks to buy according to Matthew Strobeck's Birchview Capital.
Is Biodesix, Inc. (BDSX) A Good Stock To Buy?
Our extensive research has shown that imitating the smart money can generate significant returns for retail investors, which is why we track nearly 900 active prominent money managers and analyze their...